6.06BMarket Cap
LossP/E TTM
Xenon Pharmaceuticals Inc
XENE Balance Sheet
You can check out the annual or quarterly balance sheets of Xenon Pharmaceuticals Inc here to evaluate the financial health, analyze fundamentals, and calculate key ratios for liquidity, leverage, and return on equity.
FAQs
Which balance sheet metrics matter most when analyzing XENE stock?
Important metrics include cash and short-term investments, total assets, current assets, total liabilities, current liabilities, long-term debt, shareholders' equity, retained earnings, inventory, receivables, working capital, current ratio, quick ratio, debt-to-equity ratio, and return on equity. Investors usually review these together rather than relying on one number.
What is the difference between assets, liabilities, and shareholders' equity?
Assets are resources the company owns or controls, such as cash, receivables, inventory, investments, and property. Liabilities are obligations the company owes, such as accounts payable, debt, leases, and taxes. Shareholders' equity is the residual value after liabilities are subtracted from assets.
What is the difference between current and non-current items?
Current assets and current liabilities are generally expected to be converted, used, paid, or settled within one year or one operating cycle. Non-current assets and non-current liabilities are longer-term items, such as property, long-term investments, deferred tax assets, long-term debt, and lease obligations.
How Much Cash Does Xenon Pharmaceuticals Inc Have?
In its most recent quarterly, Xenon Pharmaceuticals Inc had 545.87M in cash and cash equivalents.
How Much Are Xenon Pharmaceuticals Inc's Total Liabilities?
Xenon Pharmaceuticals Inc reported 51.40M in total liabilities as of the latest reported quarter, including 41.79M in current liabilities and 9.61M in non-current liabilities.
What Are Xenon Pharmaceuticals Inc's Total Assets?
As of the latest reported quarter, Xenon Pharmaceuticals Inc's total assets were 633.16M, consisting of 560.65M in current assets and 72.51M in non-current assets.
How Much Shareholders' Equity Does Xenon Pharmaceuticals Inc Have?
Xenon Pharmaceuticals Inc reported 581.76M in total shareholders' equity as of the latest reported quarter.